Details for Patent: 9,714,258
✉ Email this page to a colleague
Which drugs does patent 9,714,258 protect, and when does it expire?
Patent 9,714,258 protects AUGTYRO and is included in one NDA.
This patent has sixty-one patent family members in thirty countries.
Summary for Patent: 9,714,258
| Title: | Diaryl macrocycles as modulators of protein kinases |
| Abstract: | The present invention relates to certain diaryl macrocyclic compounds, pharmaceutical compositions containing them, and methods of using them, including methods for treating cancer, pain, neurological diseases, autoimmune diseases, and inflammation. |
| Inventor(s): | Cui Jingrong Jean, Li Yishan, Rogers Evan W., Zhai Dayong |
| Assignee: | TP Therapeutics, Inc. |
| Application Number: | US15113583 |
|
Patent Claim Types: see list of patent claims |
Drugs Protected by US Patent 9,714,258
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bristol | AUGTYRO | repotrectinib | CAPSULE;ORAL | 218213-001 | Nov 15, 2023 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,714,258
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 100087 | ⤷ Try a Trial | |||
| Australia | 2015209239 | ⤷ Try a Trial | |||
| Australia | 2019279951 | ⤷ Try a Trial | |||
| Canada | 2936079 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
